You misunderstand the purpose of ASX announcements. The argument you make, that these results don't prove the efficacy of Veyonda in preventing cytokine storm/septic shock, is correct. Like you, I would have liked more information about the normal course of events in untreated patients. But the results are encouraging and the market needs to be informed of that fact.
Ann: Veyonda Showing Potential to Prevent Cytokine Storm, page-40
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
